BLM
HALO icon

Bennett Lawrence Management’s Halozyme HALO Stock Holding History

Bennett Lawrence Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-24,420
Closed -$310K – 96
2014
Q1 		$310K Buy
+24,420
New +$362K 0.05% 84

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bennett Lawrence Management's HALO Position: Q2 2014 in Review

Bennett Lawrence Management sold out of Halozyme (HALO) in Q2 2014, closing a stake of 24,420 shares — an estimated $310K sold.

Bennett Lawrence Management first reported a position in HALO in Q1 2014 and held it in 1 quarter. The position peaked at $310K in Q1 2014. 128 funds tracked by Wall St. Rank hold HALO as of Q2 2014.

  • Bennett Lawrence Management reported no remaining Halozyme position as of Q2 2014 after selling out during the quarter.
  • Bennett Lawrence Management sold 24,420 Halozyme shares in Q2 2014, an estimated $310K.
  • Bennett Lawrence Management first reported a position in Halozyme in Q1 2014 and held it in 1 quarter.
  • Bennett Lawrence Management's Halozyme position peaked at $310K in Q1 2014.
  • 128 funds tracked by Wall St. Rank held Halozyme as of Q2 2014.

Based on Bennett Lawrence Management's 13F filing for Q2 2014, filed 6 Aug 2014.